Eloxx Pharmaceuticals Inc (OTCQB:ELOX)

10.35
Delayed Data
As of 3:44pm ET
 -0.05 / -0.48%
Today’s Change
3.10
Today|||52-Week Range
10.75
+29.37%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$385.6M

Company Description

Eloxx Pharmaceuticals, Inc. operates as a clinical stage company. It develops biopharmaceuticals. The company was founded on December 19, 2017 and is headquartered in Waltham, MA.

Contact Information

Eloxx Pharmaceuticals, Inc.
950 Winter Street
Waltham Massachusetts 02451
P:(781) 577-5300
Investor Relations:

Employees

Shareholders

Individual stakeholders43.78%
Mutual fund holders--
Other institutional--

Top Executives

Robert E. WardChairman & Chief Executive Officer
Dori PelledVice President-Operations
Gregory L. WeaverChief Financial & Accounting Officer
Pedro HuertasChief Medical Officer